Overt and Subclinical Hypothyroidism in the Elderly: When to Treat?

Hypothyroidism is characterized by increased thyrotropin (TSH) levels and reduced free thyroid hormone fractions while, subclinical hypothyroidism (sHT) by elevated serum TSH in the face of normal thyroid hormones. The high frequency of hypothyroidism among the general population in Western Countrie...

Full description

Bibliographic Details
Main Authors: Valeria Calsolaro, Filippo Niccolai, Giuseppe Pasqualetti, Alessia Maria Calabrese, Antonio Polini, Chukwuma Okoye, Silvia Magno, Nadia Caraccio, Fabio Monzani
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2019.00177/full
_version_ 1818940361512321024
author Valeria Calsolaro
Valeria Calsolaro
Filippo Niccolai
Giuseppe Pasqualetti
Alessia Maria Calabrese
Antonio Polini
Chukwuma Okoye
Silvia Magno
Nadia Caraccio
Fabio Monzani
author_facet Valeria Calsolaro
Valeria Calsolaro
Filippo Niccolai
Giuseppe Pasqualetti
Alessia Maria Calabrese
Antonio Polini
Chukwuma Okoye
Silvia Magno
Nadia Caraccio
Fabio Monzani
author_sort Valeria Calsolaro
collection DOAJ
description Hypothyroidism is characterized by increased thyrotropin (TSH) levels and reduced free thyroid hormone fractions while, subclinical hypothyroidism (sHT) by elevated serum TSH in the face of normal thyroid hormones. The high frequency of hypothyroidism among the general population in Western Countries made levothyroxine (LT4) one of the 10 most prescribed drugs. However, circulating TSH has been demonstrated to increase with aging, regardless the existence of an actual thyroid disease. Thus, when confronting an increase in circulating TSH levels in the elderly, especially in the oldest old, it is important to carry an appropriate diagnostic path, comprehensive of clinical picture as well as laboratory and imaging techniques. In the current review, we summarize the recommendations for a correct diagnostic workup and therapeutic approach to older people with elevated TSH value, with special attention to the presence of frailty, comorbidities, and poly-therapy. The treatment of choice for hypothyroid patients is hormone replacement with LT4 but, it is important to consider multiple factors before commencing the therapy, from the age dependent TSH increase to the presence of an actual thyroid disease and comorbidities. When treatment is necessary, a tailored therapy should be chosen, considering poly-pharmacy and frailty. A careful follow-up and treatment re-assessment should be always considered to avoid the risk of over-treatment. It is important to stress the need of educating the patient for a correct administration of LT4, particularly when poly-therapy is in place, and the importance of a tailored therapeutic approach and follow-up, to avoid overtreatment.
first_indexed 2024-12-20T06:38:25Z
format Article
id doaj.art-d0b52e3eac334b4bb2d6a5cc451b893d
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-20T06:38:25Z
publishDate 2019-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-d0b52e3eac334b4bb2d6a5cc451b893d2022-12-21T19:49:55ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922019-03-011010.3389/fendo.2019.00177438595Overt and Subclinical Hypothyroidism in the Elderly: When to Treat?Valeria Calsolaro0Valeria Calsolaro1Filippo Niccolai2Giuseppe Pasqualetti3Alessia Maria Calabrese4Antonio Polini5Chukwuma Okoye6Silvia Magno7Nadia Caraccio8Fabio Monzani9Geriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyNeurology Imaging Unit, Imperial College, London, United KingdomGeriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyGeriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyGeriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyGeriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyGeriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyObesity Center at the Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyGeriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyGeriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyHypothyroidism is characterized by increased thyrotropin (TSH) levels and reduced free thyroid hormone fractions while, subclinical hypothyroidism (sHT) by elevated serum TSH in the face of normal thyroid hormones. The high frequency of hypothyroidism among the general population in Western Countries made levothyroxine (LT4) one of the 10 most prescribed drugs. However, circulating TSH has been demonstrated to increase with aging, regardless the existence of an actual thyroid disease. Thus, when confronting an increase in circulating TSH levels in the elderly, especially in the oldest old, it is important to carry an appropriate diagnostic path, comprehensive of clinical picture as well as laboratory and imaging techniques. In the current review, we summarize the recommendations for a correct diagnostic workup and therapeutic approach to older people with elevated TSH value, with special attention to the presence of frailty, comorbidities, and poly-therapy. The treatment of choice for hypothyroid patients is hormone replacement with LT4 but, it is important to consider multiple factors before commencing the therapy, from the age dependent TSH increase to the presence of an actual thyroid disease and comorbidities. When treatment is necessary, a tailored therapy should be chosen, considering poly-pharmacy and frailty. A careful follow-up and treatment re-assessment should be always considered to avoid the risk of over-treatment. It is important to stress the need of educating the patient for a correct administration of LT4, particularly when poly-therapy is in place, and the importance of a tailored therapeutic approach and follow-up, to avoid overtreatment.https://www.frontiersin.org/article/10.3389/fendo.2019.00177/fullhypothyroidismelderlytreatmentL-thyroxinfrailty
spellingShingle Valeria Calsolaro
Valeria Calsolaro
Filippo Niccolai
Giuseppe Pasqualetti
Alessia Maria Calabrese
Antonio Polini
Chukwuma Okoye
Silvia Magno
Nadia Caraccio
Fabio Monzani
Overt and Subclinical Hypothyroidism in the Elderly: When to Treat?
Frontiers in Endocrinology
hypothyroidism
elderly
treatment
L-thyroxin
frailty
title Overt and Subclinical Hypothyroidism in the Elderly: When to Treat?
title_full Overt and Subclinical Hypothyroidism in the Elderly: When to Treat?
title_fullStr Overt and Subclinical Hypothyroidism in the Elderly: When to Treat?
title_full_unstemmed Overt and Subclinical Hypothyroidism in the Elderly: When to Treat?
title_short Overt and Subclinical Hypothyroidism in the Elderly: When to Treat?
title_sort overt and subclinical hypothyroidism in the elderly when to treat
topic hypothyroidism
elderly
treatment
L-thyroxin
frailty
url https://www.frontiersin.org/article/10.3389/fendo.2019.00177/full
work_keys_str_mv AT valeriacalsolaro overtandsubclinicalhypothyroidismintheelderlywhentotreat
AT valeriacalsolaro overtandsubclinicalhypothyroidismintheelderlywhentotreat
AT filipponiccolai overtandsubclinicalhypothyroidismintheelderlywhentotreat
AT giuseppepasqualetti overtandsubclinicalhypothyroidismintheelderlywhentotreat
AT alessiamariacalabrese overtandsubclinicalhypothyroidismintheelderlywhentotreat
AT antoniopolini overtandsubclinicalhypothyroidismintheelderlywhentotreat
AT chukwumaokoye overtandsubclinicalhypothyroidismintheelderlywhentotreat
AT silviamagno overtandsubclinicalhypothyroidismintheelderlywhentotreat
AT nadiacaraccio overtandsubclinicalhypothyroidismintheelderlywhentotreat
AT fabiomonzani overtandsubclinicalhypothyroidismintheelderlywhentotreat